Your browser doesn't support javascript.
loading
Upper eyelid Merkel cell carcinoma treated with neoadjuvant chemotherapy and surgical excision
Archives of Craniofacial Surgery ; : 121-125, 2019.
Article in English | WPRIM | ID: wpr-762750
ABSTRACT
Merkel cell carcinoma is a rare cutaneous carcinoma, featured by an aggressive clinical course and a mortality rate of 28% at 2 years. A 71-year-old female was affected by a 4.1-cm-wide locally advanced Merkel cell carcinoma of the upper eyelid, previously misdiagnosed as chalazion, with involvement of the extraocular muscles. Although the tumor showed a macroscopic spontaneous regression in size after the incisional biopsy, the mass was treated with neoadjuvant chemotherapy and surgical excision. Good functional and aesthetic result with preservation of the eyeball and absence of tumor recurrence were achieved at 3-year follow-up. In our experience, the combination of the inflammatory cascade due to the incisional biopsy and neoadjuvant chemotherapy led to the regression of a locally advanced large Merkel cell carcinoma of the eyelid.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Recurrence / Skin Neoplasms / Biopsy / Carcinoma, Merkel Cell / Follow-Up Studies / Mortality / Chalazion / Neoadjuvant Therapy / Drug Therapy / Eyelid Neoplasms Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans Language: English Journal: Archives of Craniofacial Surgery Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Recurrence / Skin Neoplasms / Biopsy / Carcinoma, Merkel Cell / Follow-Up Studies / Mortality / Chalazion / Neoadjuvant Therapy / Drug Therapy / Eyelid Neoplasms Type of study: Observational study / Prognostic study Limits: Aged / Female / Humans Language: English Journal: Archives of Craniofacial Surgery Year: 2019 Type: Article